New diabetes clinical trial: Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

Published on: August 30, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Insulin glargine, 300 U/ml;   Drug: Insulin degludec, 100U/ml;   Drug: Background therapy: Rapid acting insulin analogs
Sponsor:   Sanofi
Not yet recruiting